{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+care+drug&page=5", "query": { "intervention": "Standard of care drug", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 3392, "total_pages": 340, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+care+drug&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+of+care+drug&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-11T23:34:13.737Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03207646", "title": "Smartphone GUIded MeDication AdherencE and Rehabilitation in Patients With Coronary Artery Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease", "Acute Coronary Syndrome" ], "interventions": [ { "name": "BrightHeart®", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 63, "start_date": "2017-07-19", "completion_date": "2018-08-17", "has_results": false, "last_update_posted_date": "2018-09-10", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207646" }, { "nct_id": "NCT04188873", "title": "Cessation Screening Project", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Nicotine Dependence" ], "interventions": [ { "name": "Preparation Varenicline and Standard Duration Varenicline", "type": "DRUG" }, { "name": "Preparation Varenicline and Extended Duration Varenicline", "type": "DRUG" }, { "name": "Standard Duration Varenicline", "type": "DRUG" }, { "name": "Extended Duration Varenicline", "type": "DRUG" }, { "name": "Preparation Combination NRT and Standard Duration Combination NRT", "type": "DRUG" }, { "name": "Preparation Combination NRT and Extended Duration Combination NRT", "type": "DRUG" }, { "name": "Standard Duration Combination NRT", "type": "DRUG" }, { "name": "Extended Duration Combination NRT", "type": "DRUG" }, { "name": "Intensive Counseling", "type": "BEHAVIORAL" }, { "name": "Minimal Counseling", "type": "BEHAVIORAL" } ], "intervention_types": [ "DRUG", "BEHAVIORAL" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 538, "start_date": "2020-12-10", "completion_date": "2025-05-08", "has_results": true, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 2, "location_summary": "Madison, Wisconsin • Milwaukee, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04188873" }, { "nct_id": "NCT03467373", "title": "A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "B-Cell Lymphoma", "Non-Hodgkin Lymphoma" ], "interventions": [ { "name": "Glofitamab", "type": "DRUG" }, { "name": "Obinutuzumab (G)", "type": "DRUG" }, { "name": "Rituximab (R)", "type": "DRUG" }, { "name": "Tocilizumab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Polatuzumab vedotin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 111, "start_date": "2018-03-13", "completion_date": "2024-12-02", "has_results": false, "last_update_posted_date": "2025-01-17", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 3, "location_summary": "Birmingham, Alabama • Charlotte, North Carolina • Philadelphia, Pennsylvania", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03467373" }, { "nct_id": "NCT06488105", "title": "Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lipid Disorder", "Hypercholesterolemia", "Cardiovascular Diseases", "Atherosclerosis" ], "interventions": [ { "name": "Statin (rosuvastatin 10 or 40 mg daily, depending on risk)", "type": "DRUG" }, { "name": "Healthy Lifestyle Counseling", "type": "BEHAVIORAL" }, { "name": "Outpatient Followup", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 130, "start_date": "2024-08-05", "completion_date": "2029-03-31", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06488105" }, { "nct_id": "NCT03699319", "title": "CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "CPI 613", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "5-flurouracil", "type": "DRUG" }, { "name": "Folinic acid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "David Bajor, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 49, "start_date": "2018-12-07", "completion_date": "2024-09-23", "has_results": false, "last_update_posted_date": "2025-01-23", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03699319" }, { "nct_id": "NCT00266773", "title": "A Telephone Feedback System for Prevention of Chronic Pain Relapse", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain and Relapse Prevention" ], "interventions": [ { "name": "Chronic pain therapeutic interactive voice response (TIVR) system", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Vermont", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 158, "start_date": "2005-11", "completion_date": "2012-01", "has_results": false, "last_update_posted_date": "2013-02-18", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 1, "location_summary": "Burlington, Vermont", "locations": [ { "city": "Burlington", "state": "Vermont" } ], "official_url": "https://clinicaltrials.gov/study/NCT00266773" }, { "nct_id": "NCT05413395", "title": "Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Eczema" ], "interventions": [ { "name": "topical colloidal oatmeal formulation with a modified plant oil", "type": "OTHER" }, { "name": "topical colloidal oatmeal formulation", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "GlycosBio, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2022-06-17", "completion_date": "2024-03-01", "has_results": false, "last_update_posted_date": "2022-07-05", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05413395" }, { "nct_id": "NCT03945201", "title": "Virtual Reality-enhanced Exercise and Education in Cardiac Rehabilitation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Adherence, Patient", "Motivation", "Satisfaction" ], "interventions": [ { "name": "Virtual walking trails", "type": "OTHER" }, { "name": "Standard of care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2018-01-29", "completion_date": "2019-07-29", "has_results": false, "last_update_posted_date": "2019-08-02", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03945201" }, { "nct_id": "NCT01350245", "title": "Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Myeloid Leukemia", "Myelodysplastic Syndromes", "Biphenotypic Leukemia", "Acute Lymphocytic Leukemia", "Chronic Myeloid Leukemia", "Chronic Lymphocytic Leukemia", "Plasma Cell Neoplasms", "Lymphoma", "Hodgkin's Disease", "Aplastic Anemia" ], "interventions": [ { "name": "Total Body Irradiation (TBI)", "type": "RADIATION" }, { "name": "Donor Lymphocyte Infusion (DLI)", "type": "BIOLOGICAL" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Mycophenolate Mofetil (MMF)", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Hematopoietic stem cell transplantation (HSCT)", "type": "DEVICE" } ], "intervention_types": [ "RADIATION", "BIOLOGICAL", "DRUG", "DEVICE" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 28, "start_date": "2010-07", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2025-05-16", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01350245" }, { "nct_id": "NCT06193512", "title": "Efficacy of A Novel RinSe Device to Reduce Oral Bacteria in Intubated IntEnsive CaRe Patients: a Pilot Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Oral Bacterial Infection", "Mechanical Ventilation Complication" ], "interventions": [ { "name": "SwishKit + Oral care treatment as usual", "type": "DEVICE" }, { "name": "Oral care treatment as usual", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2024-03-08", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-04-30", "last_synced_at": "2026-10-11T23:34:13.737Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06193512" } ] }